These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22950986)

  • 1. Subungueal haemorrhages following docetaxel (taxotere) treatment.
    Fenniche S; Hammami H; Badri T; Mokhtar I; Benmously R
    Curr Drug Saf; 2012 Jul; 7(3):247-9. PubMed ID: 22950986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docetaxel-induced onycholysis: the role of subungual hemorrhage and suppuration.
    Roh MR; Cho JY; Lew W
    Yonsei Med J; 2007 Feb; 48(1):124-6. PubMed ID: 17326255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nail changes secondary to docetaxel (Taxotere).
    Correia O; Azevedo C; Pinto Ferreira E; Braga Cruz F; Polónia J
    Dermatology; 1999; 198(3):288-90. PubMed ID: 10393455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rare manifestation of nail changes with docetaxel therapy.
    Halvorson CR; Erickson CL; Gaspari AA
    Skinmed; 2010; 8(3):179-80. PubMed ID: 21137627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onycholysis and subungual haemorrhages secondary to systemic chemotherapy (paclitaxel).
    Ghetti E; Piraccini BM; Tosti A
    J Eur Acad Dermatol Venereol; 2003 Jul; 17(4):459-60. PubMed ID: 12834462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taxane-induced nail changes: incidence, clinical presentation and outcome.
    Minisini AM; Tosti A; Sobrero AF; Mansutti M; Piraccini BM; Sacco C; Puglisi F
    Ann Oncol; 2003 Feb; 14(2):333-7. PubMed ID: 12562663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docetaxel-induced nail dystrophy.
    Nicolopoulos J; Howard A
    Australas J Dermatol; 2002 Nov; 43(4):293-6. PubMed ID: 12423438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subungueal pyogenic granuloma secondary to docetaxel therapy.
    Devillers C; Vanhooteghem O; Henrijean A; Ramaut M; de la Brassinne M
    Clin Exp Dermatol; 2009 Mar; 34(2):251-2. PubMed ID: 19120399
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of taxane chemotherapy-induced nail changes and peripheral neuropathy by application of extremity cooling: a prospective single-centre study with intrapatient comparison.
    Johnson K; Stoffel B; Schwitter M; Hayoz S; Rojas Mora A; Fischer Maranta A; El Saadany T; Hasler U; von Moos R; Patzen A; Mark M; Roberts G; Cathomas R
    Support Care Cancer; 2024 Jul; 32(8):554. PubMed ID: 39066890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nail changes during docetaxel containing combination chemotherapy.
    Woo IS; Shim KH; Kim GY; Lee MA; Kang JH; Hong YS; Lee KS
    Korean J Intern Med; 2004 Jun; 19(2):132-3. PubMed ID: 15366647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docetaxel-induced acral erythema and nail changes distributed to photoexposed areas.
    Ferreira O; Baudrier T; Mota A; Duarte AF; Azevedo F
    Cutan Ocul Toxicol; 2010 Dec; 29(4):296-9. PubMed ID: 20608863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot.
    Scotté F; Banu E; Medioni J; Levy E; Ebenezer C; Marsan S; Banu A; Tourani JM; Andrieu JM; Oudard S
    Cancer; 2008 Apr; 112(7):1625-31. PubMed ID: 18286527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel-induced subungual hemorrhage.
    Vanhooteghem O; André J; Vindevoghel A; Vandenbossche L; Vandeveire A; Song M
    Dermatology; 1997; 194(4):419-20. PubMed ID: 9252781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taxane-induced nail changes: Predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity.
    Can G; Aydiner A; Cavdar I
    Eur J Oncol Nurs; 2012 Jul; 16(3):270-5. PubMed ID: 21784705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taxan-associated nail toxicity.
    Doleschal B; Petzer A; Aichberger KJ
    BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28143862
    [No Abstract]   [Full Text] [Related]  

  • 16. [Integrated podiatrist care for prostate cancer patients treated with docetaxel: Feasibility and results].
    Chabanol H; Huillard O; Prin L; Villeminey C; Rondeau A; Boudou-Rouquette P; Astorg F; Musenghesi B; Du Mortier C; Alexandre J; Goldwasser F
    Bull Cancer; 2018 Dec; 105(12):1173-1182. PubMed ID: 30078546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nail toxicity related to taxanes.
    Mourad YA; Matta-Muallem M; Shamseddine A
    Dermatol Online J; 2003 Aug; 9(3):15. PubMed ID: 12952762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of pigmentary side effects of taxanes and anthracyclines: an onychoscopic evaluation.
    Yorulmaz A; Dogan M; Artuz F; Zengin N
    Cutan Ocul Toxicol; 2017 Jun; 36(2):135-139. PubMed ID: 27086693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel-related nail toxicity.
    Yang ST; Cheng M; Lee NR; Chang WH; Lee YL; Wang PH
    Taiwan J Obstet Gynecol; 2019 Sep; 58(5):709-711. PubMed ID: 31542098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nail toxicities induced by systemic anticancer treatments.
    Robert C; Sibaud V; Mateus C; Verschoore M; Charles C; Lanoy E; Baran R
    Lancet Oncol; 2015 Apr; 16(4):e181-9. PubMed ID: 25846098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.